Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Recent Developments on Ketolides and Macrolides

Author(s): Yong-Jin Wu and Wei-Guo Su

Volume 8, Issue 14, 2001

Page: [1727 - 1758] Pages: 32

DOI: 10.2174/0929867013371671

Price: $65

Abstract

Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial infections caused by both macrolide- and β-lactam-susceptible and -resistant S. pneumoniae, gram negative bacteria, and intracellular atypical pathogens. The discovery of ketolides has rekindled interest in macrolides, and recent efforts have also led to a novel class of 4”-carbamates with activity against macrolide-resistant organisms. This review is an account of recent developments on ketolides and macrolides in terms of both chemistry and antibacterial activity.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy